T2 Biosystms Inc (TTOO) Insider Trading
- $18,549,927.79
- $15,030,621.88
- Sept. 13, 2024
- Polaris Venture Partners V, L.
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 13, 2024 | Director | 55 | $2.42 | Sell | $133.10 | |
Sept. 27, 2023 | Major Shareholder | 5,981,202 | $0.19 | Sell | $1,136,428.38 | |
Sept. 25, 2023 | Major Shareholder | 250,000 | $0.25 | Sell | $62,500.00 | |
Sept. 21, 2023 | Major Shareholder | 6,338,211 | $0.30 | Sell | $1,901,463.30 | |
Sept. 19, 2023 | Major Shareholder | 10,401,466 | $0.37 | Sell | $3,848,542.42 | |
April 8, 2022 | Insider | 12,952 | $0.50 | Buy | $6,476.00 | |
April 7, 2022 | CEO | 30,000 | $0.50 | Buy | $15,000.00 | |
April 7, 2022 | General Counsel | 10,000 | $0.49 | Buy | $4,900.00 | |
July 1, 2021 | Director | 18,182 | $1.16 | Sell | $21,091.12 | |
May 20, 2021 | Director | 5,126 | $0.80 | Buy | $4,100.80 | |
May 19, 2021 | Major Shareholder | 10,328 | $0.83 | Buy | $8,572.24 | |
May 12, 2021 | Major Shareholder | 2,500 | $0.55 | Buy | $1,375.00 | |
May 6, 2021 | Major Shareholder | 26,200 | $0.55 | Buy | $14,410.00 | |
April 9, 2021 | Major Shareholder | 1,000 | $0.49 | Buy | $490.00 | |
March 25, 2021 | General Counsel | 8,758 | $1.56 | Sell | $13,662.48 | |
March 25, 2021 | Director | 600 | $0.93 | Buy | $558.00 | |
March 24, 2021 | Major Shareholder | 500 | $0.38 | Buy | $190.00 | |
March 17, 2021 | Insider | 12,494 | $1.86 | Sell | $23,238.84 | |
Feb. 23, 2021 | CFO | 5,250 | $2.04 | Sell | $10,710.00 | |
Feb. 23, 2021 | General Counsel | 7,280 | $2.06 | Sell | $14,996.80 | |
Feb. 24, 2020 | SVP | 5,808 | $0.82 | Sell | $4,762.56 | |
Feb. 11, 2020 | Insider | 3,200 | $0.77 | Sell | $2,464.00 | |
Jan. 23, 2020 | Director | 57,417 | $1.15 | Sell | $66,029.55 | |
Jan. 3, 2020 | Director | 5,316 | $1.16 | Sell | $6,166.56 | |
Sept. 11, 2019 | SVP | 4,210 | $2.92 | Sell | $12,293.20 | |
June 11, 2019 | Director | 3,240 | $1.43 | Sell | $4,633.20 | |
Feb. 11, 2019 | General Counsel | 3,005 | $3.36 | Sell | $10,096.80 | |
Feb. 11, 2019 | CEO | 8,134 | $3.36 | Sell | $27,330.24 | |
Feb. 1, 2019 | CEO | 14,338 | $3.43 | Sell | $49,179.34 | |
Feb. 1, 2019 | General Counsel | 2,759 | $3.43 | Sell | $9,463.37 | |
Feb. 1, 2019 | Insider | 6,351 | $3.43 | Sell | $21,783.93 | |
Nov. 6, 2018 | Director | 6,048 | $5.29 | Sell | $31,993.92 | |
Sept. 19, 2018 | Insider | 138,144 | $6.18 | Sell | $853,729.92 | |
June 5, 2018 | Director | 6,000 | $8.87 | Sell | $53,220.00 | |
June 1, 2018 | Director | 4,225 | $7.65 | Buy | $32,321.25 | |
Nov. 16, 2017 | Director | 1,500 | $4.11 | Buy | $6,165.00 | |
June 6, 2017 | General Counsel | 1,000 | $3.51 | Buy | $3,510.00 | |
June 6, 2017 | COO | 5,000 | $3.50 | Buy | $17,500.00 | |
June 6, 2017 | Director | 10,000 | $3.50 | Buy | $35,000.00 | |
June 6, 2017 | CFO | 4,000 | $3.58 | Buy | $14,320.00 | |
March 15, 2017 | Director | 10,000 | $5.97 | Buy | $59,700.00 | |
June 30, 2016 | SVP | 3,589 | $8.16 | Sell | $29,286.24 | |
March 16, 2016 | SVP | 7,588 | $8.01 | Sell | $60,779.88 | |
Dec. 9, 2015 | Major Shareholder | 307,692 | $9.75 | Buy | $2,999,997.00 | |
Dec. 9, 2015 | Director | 10,000 | $9.75 | Buy | $97,500.00 | |
July 24, 2015 | Major Shareholder | 15,399 | $15.04 | Sell | $231,600.96 | |
July 22, 2015 | Major Shareholder | 14,999 | $15.22 | Sell | $228,284.78 | |
July 21, 2015 | Major Shareholder | 14,999 | $15.42 | Sell | $231,284.58 | |
July 20, 2015 | Major Shareholder | 14,999 | $16.05 | Sell | $240,733.95 | |
July 17, 2015 | Major Shareholder | 44,997 | $16.26 | Sell | $731,651.22 |
Insiders are both buying and selling T2 Biosystms Inc stock.
The insider traders at T2 Biosystms Inc are: Polaris Venture Partners V, L., David B Elsbree, Thomas J Lowery, Michael Terrence Gibbs, Goldman Sachs & Co. Llc, Alec Barclay, Group L.P. Cr, John Mcdonough, Adrian M Jones, Aisling Capital Iii Lp, Michael J Cima, Rahul Dhanda, Stanley Lapidus, John J Sperzel III, Joanne Spadoro, Thomas J Carella, Sarah O Kalil, John M. Sprague, Michael A Pfaller, and Darlene M Deptula-Hicks
The most active insider trader at T2 Biosystms Inc is Polaris Venture Partners V, L. with 14 trades.
Group L.P. Cr has sold the most T2 Biosystms Inc stock with a total value of $8,085,362.48.
Thomas J Carella has bought the most T2 Biosystms Inc stock with a total value of $19,999,980.00.
The most recent insider trade for T2 Biosystms Inc was on Sept. 13, 2024.
The single biggest insider buy for T2 Biosystms Inc was from Thomas J Carella with a total value of $9,999,990.00 on Aug. 12, 2014.
The single biggest insider sell for T2 Biosystms Inc was from Group L.P. Cr with a total value of $3,848,542.42 on Sept. 19, 2023.